ARCHIVES

Drug Cleared For GIST And Kidney Cancer, FDA’s First Two-Indication Cancer Approval

This article is from The Cancer Letter archive.

Vol. 29 No. 1 | January 27, 2006

Download PDF Visit The Full Archive

Related Articles

EntreMed Begins Pilot Phase II Trial Of Small Molecule Angiogenesis Inhibitor.

December 15, 2000

HHS Forms Rural Task Force To Study, Improve Programs.

July 27, 2001

Larynx Preservation Provides Better Voice Quality For Patients

February 29, 2008

ACS Supports NCI’s Bypass Budget In Resolution

March 20, 1992

In Brief: Three More Comprehensive Centers May Be Names; Hawaii, Cleveland, Ohio State Lead List of 10

May 9, 1975

SBIR: A Sure Fire Way to Get Funded In A Year When Applications Scoring Over 158 Are Being Dropped

February 22, 1985